Targeted proteomics technique has emerged as a powerful protein quantification tool in
systems biology, biomedical research, and increasing for clinical applications. The most …

Parkinson disease (PD) is a progressive neurodegenerative disease that affects one million
people in the United States. This article reviews the etiology and pathophysiology of PD, risk …

Background Currently there are no effective treatments for many neurodegenerative
diseases. Reliable biomarkers for identifying and stratifying these diseases will be important …

Background N-linked glycoprotein is a highly interesting class of proteins for clinical and
biological research. The large-scale characterization of N-linked glycoproteins …

Accurate, reliable, and objective biomarkers for Alzheimer's disease (AD), Parkinson's
disease (PD), and related age‐associated neurodegenerative disorders are urgently …

Objective Using a multi‐cohort, discovery‐replication‐validation design, we sought new
plasma biomarkers that predict which individuals with Parkinson's disease (PD) will …

Parkinson's disease (PD) is an age-related, threatening neurodegenerative disorder with no
reliable treatment till date. Identification of specific and reliable biomarker is a major …

Most serum proteins are N-linked glycosylated, and therefore the glycoproteomic profiling of
serum is essential for characterization of serum proteins. In this study, we profiled serum N …

Parkinson's disease is increasingly prevalent. It progresses from the pre-motor stage
(characterised by non-motor symptoms like REM sleep behaviour disorder), to the disabling …

N-linked glycoprotein is a highly interesting class of proteins for clinical and biological
research. Over the last decade, large-scale profiling of N-linked glycoproteins and …